Trials and triumphs
Through rigorous clinical trials, tesofensine's safety and efficacy have been thoroughly evaluated. In a groundbreaking study involving individuals with obesity, tesofensine demonstrated significant weight loss compared to a placebo group. Over a span of six months, participants experienced an impressive average weight reduction of approximately 12%. Moreover, tesofensine showcased positive effects on cardiovascular risk factors, including improved insulin sensitivity and reduced blood pressure.